Inicio>>Signaling Pathways>> Immunology/Inflammation>> Reactive Oxygen Species>>MitoSOX Red

MitoSOX Red

Catalog No.GC68230

MitoSOX Red is a live cell fluorescent probe targeting mitochondria with maximum excitation/emission light of 510/580 nm.

Products are for research use only. Not for human use. We do not sell to patients.

MitoSOX Red Chemical Structure

Cas No.: 1003197-00-9

Tamaño Precio Disponibilidad Cantidad
50ug (50ug in 13uL DMSO)
43,00 $
Disponible
100ug (100ug in 26uL DMSO)
70,00 $
Disponible
500ug (500ug in 130uL DMSO)
210,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents

MitoSOX Red is a live cell fluorescent probe targeting mitochondria with maximum excitation/emission light of 510/580 nm. MitoSOX Red can be used as a fluorescent indicator to specifically detect superoxide. MitoSOX Red is cell membrane permeable and can quickly and selectively target mitochondria after entering cells. After entering the mitochondria, MitoSOX Red is easily oxidized by superoxide, but not easily oxidized by other ROS or RNS generating systems, and then combines with the nucleic acid in the mitochondria to produce strong red fluorescence[1].

References:

[1]. Fengjiao Jin, et al. The PI3K/Akt/GSK-3β/ROS/eIF2B pathway promotes breast cancer growth and metastasis via suppression of NK cell cytotoxicity and tumor cell susceptibility. Cancer Biol Med. 2019 Feb;16(1):38-54.

Reseñas

Review for MitoSOX Red

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for MitoSOX Red

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.